3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Glioma
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thoracic Diseases
1
Sarcoma, Ewing
1
Prostatic Neoplasms
1
Parathyroid Neoplasms
1
Parathyroid Diseases
1
Pancreatitis
1
Oligodendroglioma
1
Musculoskeletal Diseases
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Hyperparathyroidism, Primary
1
Hemorrhage
1
Gliosarcoma
1
Glioma, Subependymal
1
Glioblastoma
1
Ependymoma
1
Disease
1
Colorectal Neoplasms
1
Choledocholithiasis
1
Cholangitis
1
Cholangiocarcinoma
1
Interventions
Radiosurgery
7
lenvatinib
5
Radiofrequency Ablation
5
Electroporation
5
Radiotherapy
3
Patient Navigation
3
Laparoscopy
3
Hepatectomy
3
Exercise
3
sintilimab
2
perflutren
2
Surgical Procedures, Operative
2
Standard of Care
2
Proton Therapy
2
Nutritional Status
2
Magnetic Resonance Spectroscopy
2
Liver Transplantation
2
Injections
2
Dextrins
2
Cryosurgery
2
Control Groups
2
Bupivacaine
2
Anesthesia, General
2
toripalimab
1
tislelizumab
1
seocalcitol
1
pembrolizumab
1
motexafin gadolinium
1
gadofosveset trisodium
1
gadobutrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Liver Neoplasms
×
Congresses as Topic
×
Clear all
NCT02784353
2022-11-17
PReHeBP
Asan Medical Center
Phase NA
Completed
158 enrolled